Hypercoagulability: another potential mechanism of obstructive sleep apnea-related cardiovascular disease?
Al Lawati
Nabil M
NM
Sleep Disorders Program and Respiratory Division, University British Columbia, Vancouver, BC, Canada.
Ayas
Najib T
NT
Sleep Disorders Program and Respiratory Division, University British Columbia, Vancouver, BC, Canada. Najib.Ayas@vch.ca.|Respiratory Division, Diamond Centre, 7th Floor, 2775 Laurel Street, Vancouver, BC, Canada, V5Z 1M9. Najib.Ayas@vch.ca.
D015415:Biomarkers / Q000097:blood; D001777:Blood Coagulation; D002318:Cardiovascular Diseases / Q000097:blood / Q000209:etiology*; D006801:Humans; D017395:Plasminogen Activator Inhibitor 1 / Q000097:blood; D018570:Risk Assessment; D012307:Risk Factors; D020181:Sleep Apnea, Obstructive / Q000097:blood* / Q000150:complications
D015415:Biomarkers; D017395:Plasminogen Activator Inhibitor 1; C051321:SERPINE1 protein, human